Stocks Listing
AXNX

Axonics, Inc.

Share
AXNX
$70.74 0.1%Last Updated Dec 02 2022 07:56 PM
1D Low / 1D High
Low:$67.42
High:$71.68
1D
0.1%
5D
9.05 %
30D
6.7 %
BulletPurple
Market Cap
$3,503,752,192
0.18 %
3.5 B
BulletBlue
Volume 1D
261,145
-
261.1 K
BulletOrange
Circulating Supply
49,530,000 AXNX
49.5 M

Price Chart

1D
5D
1M
6M
YTD
1Y
MAX
About

Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, France, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is headquartered in Irvine, California.

Historical data

1D
5D
1M
6M
1Y
MAX
Day
Open - Close
Low/High
Volume
Market Cap
Show More
Market Status
Closed
NMS
NASDAQ Stock Exchange
USA
Opens in
12 hours, 42 minutes
Working Hours
Mon-Fri, 02:30 PM - 09:00 PM
Timezone
GMT+0